Jason Harris, associate director of policy and programs at National Health Council, talks about promoting high-value, patient-centric care that reduces costs.
Jason Harris, associate director of policy and programs at National Health Council, talks about promoting high-value, patient-centric care that reduces costs.
Transcript
How can patient navigators be better used to improve patient care, patient understanding, and decision making?
They got to use it more. Obviously, there’s a different climate right now but overall that position and being that central source to help folks navigate the situation, for lack of a better term, is something that is really necessary and it’s one thing at the National Health Council we have some of the leading patient health advocacy organizations in the country and many of those groups do the same thing in terms of navigating their constituents to certain areas. Overall, that holistic environment we need to bring people together to be giving that push rather than having them to pull it out.
How is the National Health Council working to promote high-value care, while reducing costs?
We are doing a number of things. We have a value initiative we have launched in the last 2 years or so and much of that is a round of trying to understand how patients define value so we can go and start to implement things that can and can’t tie back to that. As well, we have a rubric and a get ready checklist for patient organizations to help them understand how they can become engaged in the value conversation whether that be with a value assessment body or in value-based payment, talking about how they can get involved in different programs and how they can use their advocacy to the best means possible.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
EMBARK Data Show Continued Improvements With DMD Gene Therapy
March 19th 2025Data from the EMBARK trial of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) show that benefits in functional outcomes, gene expression, and muscle imaging persist 2 years after receiving the gene therapy.
Read More
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More